Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD)

[1]  D. Umbach,et al.  The Prevalence of ADHD in a Population-Based Sample , 2015, Journal of attention disorders.

[2]  J. Endicott,et al.  Schedule for Affective Disorders and Schizophrenia , 2014 .

[3]  M. Ceylan,et al.  Serum neopterin levels in patients with autism , 2014 .

[4]  M. Ceylan,et al.  Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey , 2013, Neuropsychiatric disease and treatment.

[5]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[6]  M. Villa,et al.  Anti-Purkinje cell antibody as a biological marker in attention deficit/hyperactivity disorder: A pilot study , 2013, Journal of Neuroimmunology.

[7]  Marion Leboyer,et al.  Autism risk factors: genes, environment, and gene-environment interactions , 2012, Dialogues in clinical neuroscience.

[8]  M. Schwarz,et al.  Altered monocyte activation markers in Tourette’s syndrome: a case–control study , 2012, BMC Psychiatry.

[9]  M. Ceylan,et al.  Changes in oxidative stress and cellular immunity serum markers in attention‐deficit/hyperactivity disorder , 2012, Psychiatry and clinical neurosciences.

[10]  N. Ryan,et al.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version , 2011 .

[11]  Inbal Goshen,et al.  Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.

[12]  T. Çaycı,et al.  The association between serum levels of neopterin and number of depressive episodes of major depression , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  Jan K. Buitelaar,et al.  Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder , 2010, European Child & Adolescent Psychiatry.

[14]  J. Carcillo,et al.  Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[15]  A. Anıl,et al.  Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity. , 2008, World journal of gastroenterology.

[16]  J. Leckman,et al.  Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  Heather A. Young,et al.  Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink , 2008, Journal of the Neurological Sciences.

[18]  S. Gau,et al.  Attention-Deficit/Hyperactivity–Related Symptoms Among Children With Enterovirus 71 Infection of the Central Nervous System , 2008, Pediatrics.

[19]  G. Willemsen,et al.  Genetic etiology of stability of attention problems in young adulthood , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[20]  F. Rice,et al.  Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. , 2005, Minerva pediatrica.

[21]  Saral Yunus,et al.  Activation Markers in Behçet's Disease , 2005 .

[22]  S. Faraone,et al.  Attention-deficit hyperactivity disorder , 2005, The Lancet.

[23]  S. Cesur [Neopterin: a marker used for monitoring infections]. , 2005, Mikrobiyoloji bulteni.

[24]  V. Harpin,et al.  The effect of ADHD on the life of an individual, their family, and community from preschool to adult life , 2005, Archives of Disease in Childhood.

[25]  C. McDougle,et al.  High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.

[26]  D. Fuchs,et al.  Potential role of immune system activation-associated production of neopterin derivatives in humans , 2003, Inflammation Research.

[27]  Joseph Biederman,et al.  The worldwide prevalence of ADHD: is it an American condition? , 2003, World psychiatry : official journal of the World Psychiatric Association.

[28]  Scott T. Grafton,et al.  A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response , 2002, Neuropsychopharmacology.

[29]  D. Waldrep Two cases of ADHD following GABHS infection: a PANDAS subgroup? , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  A. Bhutta,et al.  Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. , 2002, JAMA.

[31]  D. Fuchs,et al.  Increased neopterin production and tryptophan degradation in advanced Parkinson's disease , 2002, Journal of Neural Transmission.

[32]  K. Żwirska-Korczala,et al.  Neopterin measurement in clinical diagnosis , 2001, Journal of clinical pharmacy and therapeutics.

[33]  S. Faraone,et al.  Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. , 1998, Journal of clinical child psychology.

[34]  D. Fuchs,et al.  Neopterin, a prognostic marker in human malignancies. , 2010, Cancer letters.

[35]  R. Joober,et al.  Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. , 2008, Journal of psychiatry & neuroscience : JPN.

[36]  D. Rossignol,et al.  Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. , 2007, Medical hypotheses.

[37]  M. Chiariello,et al.  The role of Neopterin in cardiovascular disease Il ruolo della neopterina nelle malattie cardiovascolari , 2007 .

[38]  Y. Saral,et al.  Activation markers in Behçet's disease. , 2005, Skinmed.

[39]  L. Foster,et al.  ADHD and the Nature of Self-Control. , 2000 .